AbbVie Inc. (ABBV)
Data as of September 4, 2026 · Drug Manufacturers - General
Stockbruh grade: Mixed 3/5 metrics rated Sunny
What does AbbVie Inc. do?
AbbVie Inc. is a worldwide pharmaceutical company based in North Chicago, Illinois 🌍. They're all about discovering and developing amazing therapies like HUMIRA for autoimmune diseases, SKYRIZI for psoriasis, and IMBRUVICA for leukemia. They also have a range of products, from pancreatic enzyme therapy to eye care solutions 👀.
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ☀️ Strong | 5-year price performance |
| Profitability | ☀️ Strong | Net margin & return on equity |
| Growth | ⛈️ Weak | Revenue & earnings trend |
| Earnings | ☀️ Strong | EPS vs analyst expectations |
| Cash & Debt | ⛈️ Weak | Balance sheet strength |
| Price | $260.21 | Market Cap | — |
| Exchange | New York Stock Exchange | | |
Plain-English Analysis
What's it worth?
Based on 5-year performance trends, AbbVie Inc. has historically delivered strong returns. Sign up free for full valuation analysis including P/E, DCF estimates, and Stockbruh's plain-English take on whether this stock looks cheap or expensive right now.
Are they building the future?
Growth has been challenging recently. Revenue or earnings are showing weak trends. Sign up free to see the full picture including forward projections.
What's ahead?
Recent earnings have been strong, meeting or beating analyst expectations. Sign up free for earnings history, EPS trends, and what analysts are forecasting next.